Mitsubishi Chemical to Sell Drug Unit to Bain in $3.36 Billion Deal
Japan's Mitsubishi Chemical said on Friday it will sell pharmaceutical unit Tanabe Mitsubishi Pharma to U.S. private equity firm Bain Capital in a deal worth 510 billion yen ($3.36 billion) as it ...
Bain Capital to Buy Mitsubishi Chemical’s Pharma Business for More Than $3 Billion
The Japanese chemical company has agreed to sell its pharmaceutical business to Bain Capital for more than $3 billion, in a ...
Mitsubishi Chemical sells pharmaceuticals subsidiary to Bain in $3.36 billion deal
Japan's Mitsubishi Chemical said on Friday it will sell pharmaceutical subsidiary Tanabe Mitsubishi Pharma to U.S. private ...
PE Hub15h
Bain Capital to acquire Tanabe Pharma in a carveout from Mitsubishi Chemical Group
Bain Capital has agreed to acquire Tanabe Pharma, the pharma arm of Mitsubishi Chemical Group Corporation. The deal puts Tanabe Pharma at a valuation of about $3.3 billion. Founded in 1678, Tanabe ...
C&EN5h
Cleaning industry fears loss of EPA’s Safer Choice chemical program
Leaders across the cleaning product supply chain are sounding the alarm about the prospect of losing the Safer Choice program run by the US Environmental Protection Agency. Safer Choice is a voluntary ...